Embecta Corp. (EMBC) shareholders
EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3079% below fair value
$6.46+0.03 (+0.47%)
Close on Nov 13, 2026Market cap $366.02MP/E 4.4Yield 9.29%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
88.9%
50M of 57M shares
Institutional holders
320
64 new, 72 sold out
Net institutional buying
-10M
In Q2 2026
Insider trades, 12 months
4 buys · 1 sales
Net bought $520.85K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 4,554,394 | 7.70% | 13G (passive) amendment | Jun 30, 2026 |
| Yacktman Asset Management LP Joint filing with Amg Yacktman Fund (5.07%) | 3,671,877 | 6.20% | 13G (passive) | Mar 31, 2026 |
| Stowers Institute for Medical Research Joint filing with American Century Investment Management, Inc. (5.80%), American Century Companies, Inc. (5.80%) | 3,439,512 | 5.80% | 13G (passive) amendment | Mar 31, 2026 |
| Vanguard Capital Management | 3,004,501 | 5.07% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of EMBC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,599,771 | 8.12% | $15.00M | −4,567,441 | 0.00% |
| Yacktman Asset Management LP | 4,315,952 | 7.62% | $14.07M | +644,075 | 0.17% |
| Vanguard Capital Management LLC | 2,557,148 | 4.51% | $8.34M | −6,803 | 0.00% |
| Deerfield Management Company, L.P. (Series C) | 2,534,961 | 4.47% | $8.26M | – | 0.09% |
| Jefferies Financial Group Inc. | 2,355,117 | 4.16% | $7.68M | −45 | 0.05% |
| Ameriprise Financial Inc | 2,038,731 | 3.60% | $6.65M | +1,239,043 | 0.00% |
| Morgan Stanley | 1,996,747 | 3.52% | $6.51M | +1,386,943 | 0.00% |
| State Street Corp | 1,610,666 | 2.84% | $5.25M | −935,307 | 0.00% |
| Geode Capital Management, LLC | 1,594,457 | 2.81% | $5.20M | +128,810 | 0.00% |
| Brigade Capital Management, LP | 1,516,453 | 2.68% | $4.94M | New | 0.93% |
| Goldman Sachs Group Inc | 1,162,041 | 2.05% | $3.79M | +413,586 | 0.00% |
| Krensavage Asset Management, LLC | 1,135,340 | 2.00% | $3.70M | +400,000 | 1.41% |
| Vanguard Portfolio Management LLC | 1,098,389 | 1.94% | $3.58M | −439,568 | 0.00% |
| Charles Schwab Investment Management Inc | 1,069,786 | 1.89% | $3.49M | −122,247 | 0.00% |
| Jacobs Levy Equity Management, Inc | 1,027,514 | 1.81% | $3.35M | New | 0.01% |
| Aqr Capital Management LLC | 976,587 | 1.72% | $3.17M | +644,984 | 0.00% |
| Millennium Management LLC | 945,968 | 1.67% | $3.08M | −648,177 | 0.00% |
| Acadian Asset Management LLC | 861,281 | 1.52% | $2.80M | +561,078 | 0.00% |
| UBS Group AG | 829,099 | 1.46% | $2.70M | +399,049 | 0.00% |
| D. E. Shaw & Co., Inc. | 650,070 | 1.15% | $2.12M | +117,742 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 320 | 50M | 88.9% | 64 / 80 | 75 / 72 | 15M | 25M |
| Q1 2026 | 339 | 61M | 100.0% | 41 / 92 | 94 / 57 | 14M | 7M |
| Q4 2025 | 363 | 58M | 100.0% | 53 / 98 | 97 / 37 | 6M | 4M |
| Q3 2025 | 353 | 57M | 99.9% | 50 / 68 | 118 / 54 | 5M | 6M |
| Q2 2025 | 359 | 58M | 100.0% | 49 / 83 | 110 / 53 | 8M | 7M |
| Q1 2025 | 367 | 57M | 100.0% | 43 / 84 | 108 / 40 | 7M | 5M |
| Q4 2024 | 367 | 55M | 97.9% | 46 / 73 | 114 / 42 | 5M | 4M |
| Q3 2024 | 366 | 55M | 96.8% | 53 / 59 | 126 / 43 | 13M | 5M |
| Q2 2024 | 361 | 56M | 99.1% | 48 / 93 | 106 / 50 | 4M | 5M |
| Q1 2024 | 371 | 57M | 100.0% | 39 / 78 | 136 / 38 | 4M | 4M |
| Q4 2023 | 374 | 56M | 99.6% | 50 / 81 | 124 / 45 | 7M | 7M |
| Q3 2023 | 373 | 57M | 99.8% | 32 / 84 | 139 / 52 | 12M | 10M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
257 funds held EMBC in Q1 2026, 49% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of EMBC | Value | % of fund | As of |
|---|---|---|---|---|---|
| AMG Yacktman Fund | 3,500,000 | 6.18% | $11.41M | 0.16% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,831,834 | 3.23% | $5.97M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,633,537 | 2.88% | $5.33M | 0.01% | Jun 30, 2026 |
| Columbia Small Cap Value Discovery Fund | 1,362,130 | 2.40% | $4.96M | 0.20% | Jul 31, 2026 |
| Fidelity Small Cap Index Fund | 684,471 | 1.21% | $2.49M | 0.01% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 668,682 | 1.18% | $2.18M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 539,388 | 0.95% | $1.76M | 0.01% | Jun 30, 2026 |
| Schwab Fundamental U.S. Small Company ETF | 457,597 | 0.81% | $1.55M | 0.02% | May 31, 2026 |
| PIMCO RAE US Small Fund | 342,162 | 0.60% | $1.12M | 0.03% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 305,199 | 0.54% | $1.03M | 0.01% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 303,260 | 0.54% | $1.03M | 0.00% | May 31, 2026 |
| Vanguard U.S. Value Factor ETF | 293,504 | 0.52% | $992.04K | 0.12% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 279,317 | 0.49% | $944.09K | 0.00% | May 31, 2026 |
| WisdomTree U.S. SmallCap Dividend Fund | 259,196 | 0.46% | $844.98K | 0.04% | Jun 30, 2026 |
| Columbia Variable Portfolio - Small Cap Value Discovery Fund | 246,450 | 0.43% | $803.43K | 0.18% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Devdatt Kurdikar | President and CEO, Director | 804,919 | 1.42% | Aug 13, 2026 |
| Jeffrey Z. Mann | Pres, Pharm Svc&Prod Mgmt, CLO | 262,915 | 0.46% | Aug 13, 2026 |
| Jacob Elguicze | SVP and CFO | 309,139 | 0.55% | Aug 13, 2026 |
| Jean Casner | Chief Human Resources Officer | 85,915 | 0.15% | Aug 11, 2026 |
| Anthony M. Roth | VP, Chief Accounting Officer | 78,833 | 0.14% | Jun 2, 2026 |
| Shaun Curtis | SVP, Global Manuf./Sup. Chain | 95,324 | 0.17% | Dec 1, 2025 |
| Milton Mayo Morris | Director | 53,828 | 0.10% | Sep 8, 2026 |
| Robert J. Hombach | Director | 109,587 | 0.19% | Aug 13, 2026 |
| Christopher R. Reidy | Director | 70,122 | 0.12% | Feb 13, 2026 |
| Karen Prange | Director | 64,581 | 0.11% | Feb 13, 2026 |
| Carrie L. Anderson | Director | 64,581 | 0.11% | Feb 13, 2026 |
| Claire Pomeroy | Director | 66,127 | 0.12% | Feb 13, 2026 |
| David F. Melcher | Director | 86,681 | 0.15% | May 23, 2025 |
| David Albritton | Director | 39,743 | 0.07% | Feb 14, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Milton Mayo Morris Director | Sep 4, 2026 | Sale | −6,293 | $5.88 | $37.00K | 53,828 |
| Robert J. Hombach Director | Aug 12, 2026 | Buy | +45,000 | $4.97 | $223.65K | 109,587 |
| Jacob Elguicze SVP and CFO | Aug 12, 2026 | Buy | +20,000 | $4.67 | $93.40K | 309,139 |
| Jeffrey Z. Mann Pres, Pharm Svc&Prod Mgmt, CLO | Aug 12, 2026 | Buy | +20,000 | $4.99 | $99.80K | 262,915 |
| Devdatt Kurdikar President and CEO, Director | Aug 12, 2026 | Buy | +30,000 | $4.70 | $141.00K | 804,919 |
| Jean Casner Chief Human Resources Officer | Aug 9, 2026 | Tax withholding | −1,480 | $4.42 | $6.54K | 85,915 |
| Anthony M. Roth VP, Chief Accounting Officer | Jun 1, 2026 | Award | +30,000 | – | – | 78,833 |
| Milton Mayo Morris Director | Feb 11, 2026 | Award | +22,841 | – | – | 60,121 |
| Carrie L. Anderson Director | Feb 11, 2026 | Award | +22,841 | – | – | 64,581 |
| Christopher R. Reidy Director | Feb 11, 2026 | Award | +22,841 | – | – | 70,122 |
| Claire Pomeroy Director | Feb 11, 2026 | Award | +22,841 | – | – | 66,127 |
| Robert J. Hombach Director | Feb 11, 2026 | Award | +22,841 | – | – | 64,587 |
| Karen Prange Director | Feb 11, 2026 | Award | +22,841 | – | – | 64,581 |
| Devdatt Kurdikar President and CEO, Director | Nov 26, 2025 | Tax withholding | −128,630 | $12.57 | $1.62M | 774,919 |
| Devdatt Kurdikar President and CEO, Director | Nov 26, 2025 | Award | +103,626 | – | – | 903,549 |
| Devdatt Kurdikar President and CEO, Director | Nov 26, 2025 | Award | +288,386 | – | – | 799,923 |
| Jacob Elguicze SVP and CFO | Nov 26, 2025 | Award | +95,466 | – | – | 267,863 |
| Jacob Elguicze SVP and CFO | Nov 26, 2025 | Award | +30,147 | – | – | 298,010 |
| Jacob Elguicze SVP and CFO | Nov 26, 2025 | Tax withholding | −24,782 | $12.57 | $311.51K | 273,228 |
| Anthony M. Roth Chief Accounting Officer | Nov 26, 2025 | Award | +32,817 | – | – | 49,296 |
| Anthony M. Roth Chief Accounting Officer | Nov 26, 2025 | Tax withholding | −1,881 | $12.57 | $23.64K | 47,415 |
| Jeffrey Z. Mann SVP, GC, Head Corp. Dev., Secy | Nov 26, 2025 | Tax withholding | −19,605 | $12.57 | $246.43K | 227,004 |
| Jeffrey Z. Mann SVP, GC, Head Corp. Dev., Secy | Nov 26, 2025 | Award | +79,555 | – | – | 222,114 |
| Jeffrey Z. Mann SVP, GC, Head Corp. Dev., Secy | Nov 26, 2025 | Award | +24,495 | – | – | 246,609 |
| Jean Casner Chief Human Resources Officer | Nov 26, 2025 | Award | +38,783 | – | – | 88,030 |
| Jean Casner Chief Human Resources Officer | Nov 26, 2025 | Tax withholding | −3,325 | $12.57 | $41.80K | 84,705 |
| Shaun Curtis SVP, Global Manuf./Sup. Chain | Nov 26, 2025 | Tax withholding | −15,380 | $12.57 | $193.33K | 95,324 |
| Shaun Curtis SVP, Global Manuf./Sup. Chain | Nov 26, 2025 | Award | +11,305 | – | – | 110,704 |
| Shaun Curtis SVP, Global Manuf./Sup. Chain | Nov 26, 2025 | Award | +37,789 | – | – | 99,399 |
| Jean Casner Chief Human Resources Officer | Aug 9, 2025 | Tax withholding | −916 | $12.28 | $11.25K | 48,799 |
| David F. Melcher Director | May 23, 2025 | Buy | +10,000 | $10.60 | $106.00K | 86,681 |
| Shaun Curtis SVP, Global Manuf./Sup. Chain | Apr 4, 2025 | Tax withholding | −3,249 | $12.00 | $38.99K | 59,061 |
| Devdatt Kurdikar President and CEO, Director | Apr 4, 2025 | Tax withholding | −39,592 | $12.00 | $475.10K | 499,582 |
| Jacob Elguicze SVP and CFO | Apr 4, 2025 | Tax withholding | −4,948 | $12.00 | $59.38K | 168,599 |
| Jeffrey Z. Mann SVP, GC, Head Corp. Dev., Secy | Apr 4, 2025 | Tax withholding | −5,285 | $12.00 | $63.42K | 139,439 |
| David F. Melcher Director | Feb 25, 2025 | Buy | +13,000 | $13.67 | $177.71K | 76,681 |
| Milton Mayo Morris Director | Feb 13, 2025 | Sale | −3,100 | $16.38 | $50.78K | 36,133 |
| Claire Pomeroy Director | Feb 12, 2025 | Award | +13,839 | – | – | 41,289 |
| Karen Prange Director | Feb 12, 2025 | Award | +13,839 | – | – | 39,743 |
| Carrie L. Anderson Director | Feb 12, 2025 | Award | +13,839 | – | – | 39,743 |
| Christopher R. Reidy Director | Feb 12, 2025 | Award | +13,839 | – | – | 45,284 |
| Milton Mayo Morris Director | Feb 12, 2025 | Award | +13,839 | – | – | 39,233 |
| Robert J. Hombach Director | Feb 12, 2025 | Award | +13,839 | – | – | 39,749 |
| David F. Melcher Director | Feb 12, 2025 | Award | +17,450 | – | – | 63,681 |
| David Albritton Director | Feb 12, 2025 | Award | +13,839 | – | – | 39,743 |
| Anthony M. Roth Chief Accounting Officer | Dec 2, 2024 | Award | +15,762 | – | – | 15,762 |
| Jeffrey Z. Mann SVP, GC, Head Corp. Dev., Secy | Nov 26, 2024 | Award | +50,803 | – | – | 150,584 |
| Jeffrey Z. Mann SVP, GC, Head Corp. Dev., Secy | Nov 26, 2024 | Tax withholding | −8,016 | $18.70 | $149.90K | 142,568 |
| Devdatt Kurdikar President and CEO, Director | Nov 26, 2024 | Tax withholding | −48,956 | $18.70 | $915.48K | 531,240 |
| Devdatt Kurdikar President and CEO, Director | Nov 26, 2024 | Award | +187,166 | – | – | 580,196 |
| Jean Casner Chief Human Resources Officer | Nov 26, 2024 | Tax withholding | −1,281 | $18.70 | $23.95K | 48,288 |
| Jean Casner Chief Human Resources Officer | Nov 26, 2024 | Award | +23,396 | – | – | 49,569 |
| Shaun Curtis SVP, Global Manuf./Sup. Chain | Nov 26, 2024 | Award | +24,065 | – | – | 67,194 |
| Shaun Curtis SVP, Global Manuf./Sup. Chain | Nov 26, 2024 | Tax withholding | −5,806 | $18.70 | $108.57K | 61,388 |
| Jacob Elguicze SVP and CFO | Nov 26, 2024 | Tax withholding | −9,785 | $18.70 | $182.98K | 170,882 |
| Jacob Elguicze SVP and CFO | Nov 26, 2024 | Award | +61,498 | – | – | 180,667 |
| Jean Casner Chief Human Resources Officer | Aug 9, 2024 | Tax withholding | −916 | $15.39 | $14.10K | 26,000 |
| Jacob Elguicze SVP and CFO | May 10, 2024 | Tax withholding | −1,013 | $14.24 | $14.43K | 117,633 |
| Devdatt Kurdikar President and CEO, Director | Apr 4, 2024 | Tax withholding | −4,535 | $12.78 | $57.96K | 388,005 |
| David F. Melcher Director | Feb 12, 2024 | Buy | +2,000 | $16.25 | $32.50K | 45,080 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
10.68%
6M shares short
Days to cover
6.8
At 1M shares a day
Change since last report
-0.9%
From 6M shares
Short volume, 20 days
57.4%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Embecta's stock actually held short. Settlement fails (shares not delivered on time) peaked at 7,745 shares on Sep 8, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Milton Mayo Morris Director | Sep 4, 2026 | 6,293 | $36.89K | Sep 4, 2026 | DIRECTORS COMPENSATION |
| Milton Mayo Morris Director | Feb 13, 2025 | 3,100 | $50.78K | Feb 13, 2025 | STOCK GRANT |
See a number that looks wrong?